Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Palm Desert, CA
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Palm Desert, CA
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
San Francisco, CA
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Santa Maria, CA
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Santa Maria, CA
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Miami, FL
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Orlando, FL
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Atlanta, GA
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Idaho Falls, ID
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Chicago, IL
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Lexington, KY
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Saint Louis, MO
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Omaha, NE
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
New York, NY
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Toledo, OH
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Tulsa, OK
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Bethlehem, PA
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Duncansville, PA
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Columbia, SC
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Dallas, TX
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Houston, TX
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Lubbock, TX
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Lubbock, TX
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
Clinical Research Facility
mi
from
Tacoma, WA
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated:  6/27/2017
mi
from
Buenos Aires,
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
Status: Enrolling
Updated: 6/27/2017
mi
from
Buenos Aires,
Click here to add this to my saved trials
Conventional Alignment System Versus Surgical Navigation System in Total Knee Arthroplasty
Conventional Tibial Extramedullary Alignment System Versus a Hand-Held, Surgical Navigation System for Tibial Component Placement in Total Knee Arthroplasty: A Randomized, Controlled Trial
Status: Enrolling
Updated:  7/10/2017
Hospital for Special Surgery
mi
from
New York, NY
Conventional Alignment System Versus Surgical Navigation System in Total Knee Arthroplasty
Conventional Tibial Extramedullary Alignment System Versus a Hand-Held, Surgical Navigation System for Tibial Component Placement in Total Knee Arthroplasty: A Randomized, Controlled Trial
Status: Enrolling
Updated: 7/10/2017
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
The Health Access and Recovery Peer Program
A Peer-Led, Medical Disease Self-Management Program for Mental Health Consumers
Status: Enrolling
Updated:  7/12/2017
Central Fulton Community Mental Health Center at Grady Hospital
mi
from
Atlanta, GA
The Health Access and Recovery Peer Program
A Peer-Led, Medical Disease Self-Management Program for Mental Health Consumers
Status: Enrolling
Updated: 7/12/2017
Central Fulton Community Mental Health Center at Grady Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Comparison of Manual Physical Therapy and Corticosteroid Injections for Knee Osteoarthritis
Orthopaedic Manual Physical Therapy Versus Corticosteroid Injections for Osteoarthritis of the Knee
Status: Enrolling
Updated:  7/31/2017
Brooke Army Medical Center
mi
from
San Antonio, TX
A Comparison of Manual Physical Therapy and Corticosteroid Injections for Knee Osteoarthritis
Orthopaedic Manual Physical Therapy Versus Corticosteroid Injections for Osteoarthritis of the Knee
Status: Enrolling
Updated: 7/31/2017
Brooke Army Medical Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Comparison of Manual Physical Therapy and Corticosteroid Injections for Knee Osteoarthritis
Orthopaedic Manual Physical Therapy Versus Corticosteroid Injections for Osteoarthritis of the Knee
Status: Enrolling
Updated:  7/31/2017
Madigan Army Medical Center
mi
from
Tacoma, WA
A Comparison of Manual Physical Therapy and Corticosteroid Injections for Knee Osteoarthritis
Orthopaedic Manual Physical Therapy Versus Corticosteroid Injections for Osteoarthritis of the Knee
Status: Enrolling
Updated: 7/31/2017
Madigan Army Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Southwest Shoulder, Elbow and Hand Center
mi
from
Tucson, AZ
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Southwest Shoulder, Elbow and Hand Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Bloomington Bone and Joint Clinic
mi
from
Bloomington, IN
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Bloomington Bone and Joint Clinic
mi
from
Bloomington, IN
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Reconstructive Hand Surgeons of Indiana
mi
from
Carmel, IN
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Reconstructive Hand Surgeons of Indiana
mi
from
Carmel, IN
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Indiana Hand Center
mi
from
Indianapolis, IN
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Indiana Hand Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
The Center for Ortho/ Neuro Care & Research
mi
from
Bend, OR
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
The Center for Ortho/ Neuro Care & Research
mi
from
Bend, OR
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
ROC Houston, PA
mi
from
Houston, TX
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
ROC Houston, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Fondren Orthopedic Group, L.L.P.
mi
from
Houston, TX
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Fondren Orthopedic Group, L.L.P.
mi
from
Houston, TX
Click here to add this to my saved trials
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated:  8/7/2017
Hand Center of San Antonio
mi
from
San Antonio, TX
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
Status: Enrolling
Updated: 8/7/2017
Hand Center of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Comparison of Exparel Local Anesthetic in Total Knee Arthroplasty (TKA) Patients
A Prospective Randomized Case Series Comparison on the Clinical Efficacy of Exparel Local Anesthetic in Total Knee Arthroplasty Patients
Status: Enrolling
Updated:  8/8/2017
Holy Cross Hospital Orthopedic Research Institute
mi
from
Fort Lauderdale, FL
A Comparison of Exparel Local Anesthetic in Total Knee Arthroplasty (TKA) Patients
A Prospective Randomized Case Series Comparison on the Clinical Efficacy of Exparel Local Anesthetic in Total Knee Arthroplasty Patients
Status: Enrolling
Updated: 8/8/2017
Holy Cross Hospital Orthopedic Research Institute
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand
An Outcome Study of Rheumatoid Hand Arthroplasty
Status: Enrolling
Updated:  8/21/2017
Curtis National Hand Center
mi
from
Baltimore, MD
Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand
An Outcome Study of Rheumatoid Hand Arthroplasty
Status: Enrolling
Updated: 8/21/2017
Curtis National Hand Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand
An Outcome Study of Rheumatoid Hand Arthroplasty
Status: Enrolling
Updated:  8/21/2017
University of Michigan
mi
from
Ann Arbor, MI
Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand
An Outcome Study of Rheumatoid Hand Arthroplasty
Status: Enrolling
Updated: 8/21/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand
An Outcome Study of Rheumatoid Hand Arthroplasty
Status: Enrolling
Updated:  8/21/2017
Pulvertaft Hand Centre
mi
from
Derby,
Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand
An Outcome Study of Rheumatoid Hand Arthroplasty
Status: Enrolling
Updated: 8/21/2017
Pulvertaft Hand Centre
mi
from
Derby,
Click here to add this to my saved trials
Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica
Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica
Status: Enrolling
Updated:  8/22/2017
Lahey Arlington
mi
from
Arlington, MA
Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica
Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica
Status: Enrolling
Updated: 8/22/2017
Lahey Arlington
mi
from
Arlington, MA
Click here to add this to my saved trials
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  9/5/2017
Clinical Research Facility
mi
from
Birmingham, AL
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 9/5/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  9/5/2017
Clinical Research Facility
mi
from
Hemet, CA
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 9/5/2017
Clinical Research Facility
mi
from
Hemet, CA
Click here to add this to my saved trials
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  9/5/2017
Clinical Research Facility
mi
from
La Palma, CA
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 9/5/2017
Clinical Research Facility
mi
from
La Palma, CA
Click here to add this to my saved trials
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  9/5/2017
Clinical Research Facility
mi
from
Los Angeles, CA
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 9/5/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  9/5/2017
Clinical Research Facility
mi
from
Los Angeles, CA
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 9/5/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  9/5/2017
Clinical Research Facility
mi
from
Ventura, CA
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 9/5/2017
Clinical Research Facility
mi
from
Ventura, CA
Click here to add this to my saved trials
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  9/5/2017
Clinical Research Facility
mi
from
Hialeah, FL
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 9/5/2017
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  9/5/2017
Clinical Research Facility
mi
from
Homestead, FL
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 9/5/2017
Clinical Research Facility
mi
from
Homestead, FL
Click here to add this to my saved trials
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  9/5/2017
Clinical Research Facility
mi
from
Miami Lakes, FL
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 9/5/2017
Clinical Research Facility
mi
from
Miami Lakes, FL
Click here to add this to my saved trials